Table 2 Preoperative and intraoperative data
Parameter | SV group * n = 152 | TAR group * n = 98 | p-value |
|---|---|---|---|
Antiplatelet therapy | |||
ASA | 137 (93) | 86 (91) | 0.44 |
Ticagrelor | 9 (6.1) | 10 (11) | 0.20 |
Prasugrel | 3 (2.0) | 3 (3.2) | 0.57 |
Clopidogrel | 44 (30) | 20 (22) | 0.16 |
DAPT | 51 (34) | 32 (33) | 0.71 |
Tirofiban | 90 (60) | 61 (65) | 0.41 |
Vitamin K antagonists | 6 (4.1) | 1 (1.0) | 0.082 |
Time interval symptom onset to operation (h)** | 72 ± 5.1 | 72 ± 5.3 | 0.85 |
Grafts | |||
LIMA | 147 (97) | 98 (100) | < 0.001 |
RIMA | 2 (1.3) | 84 (86) | |
Radial artery | 0 | 18 (18) | |
Saphenous vein | 152 (100) | 0 | |
Coronary anastomoses | |||
Total | 3.8 ± 1.1 | 3.6 ± 1.0 | 0.11 |
Arterial grafts | 1.5 ± 0.6 | 3.6 ± 1.0 | < 0.001 |
Venous grafts | 2.3 ± 1.0 | 0 | < 0.001 |
Target vessels | |||
LAD | 151 (99) | 98 (100) | 0.42 |
RCX | 132 (89) | 87 (89) | 0.59 |
RCA | 116 (76) | 80 (82) | 0.32 |
Complete revascularization [n; %] | 149 (99) | 95 (97) | 0.69 |